Bio-key International, Inc. (BKYI) Misses Q2 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BKYI Hot Sheet
Price: $2.36 --0%
Revenue Growth %: +54.8%
Financial Fact:
[CostOfRevenue]: 171.78K
Today's EPS Names:
KTB, CABO, FDUS, More
Revenue Growth %: +54.8%
Financial Fact:
[CostOfRevenue]: 171.78K
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Bio-key International, Inc. (NASDAQ: BKYI) reported Q2 EPS of ($0.20). Revenue for the quarter came in at $1.7 million.
For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ecovyst Inc. (ECVT) Tops Q3 EPS by 2c
- Sezzle Inc. (SEZL) Reports Q3 EPS of $1.37 ; Offers Guidance
- UBS Upgrades Hunan Yuneng New Energy Battery (301358:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
